Skip to main content

Repare Therapeutics Inc.

RPTXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001808158

Repare Therapeutics Inc. was delisted in 2026; its insiders filed their last Form 4 on Jan 30, 2026; 46 institutions reported holding it in 13F filings for Q4 2025, worth $65.4M in total; no superinvestor held it.

13F holders, Q4 2025

Institutional positions in Repare Therapeutics Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

RPTX is no longer listed, so this page shows Q4 2025. 13F filings for later quarters list far fewer holders.

Institutional holders
46
+2 vs. Q3 2025
Shares held
25.2M
−988.9K (−3.8%) vs. Q3 2025
Total value
$65.4M
+$19.4M (+42.2%) vs. Q3 2025
New holders
13
8 more added
Sold out
11
8 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RPTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 46 institutions
Q1 2021: 65 institutionsQ2 2021: 61 institutionsQ3 2021: 66 institutionsQ4 2021: 67 institutionsQ1 2022: 62 institutionsQ2 2022: 71 institutionsQ3 2022: 71 institutionsQ4 2022: 82 institutionsQ1 2023: 77 institutionsQ2 2023: 78 institutionsQ3 2023: 76 institutionsQ4 2023: 69 institutionsQ1 2024: 71 institutionsQ2 2024: 61 institutionsQ3 2024: 56 institutionsQ4 2024: 54 institutionsQ1 2025: 50 institutionsQ2 2025: 50 institutionsQ3 2025: 45 institutionsQ4 2025: 46 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2025: $65.4M
Q1 2021: $797.7MQ2 2021: $828.3MQ3 2021: $707.7MQ4 2021: $689.5MQ1 2022: $464.3MQ2 2022: $451.7MQ3 2022: $398.1MQ4 2022: $491.9MQ1 2023: $326.7MQ2 2023: $379.2MQ3 2023: $437.7MQ4 2023: $266.6MQ1 2024: $167.2MQ2 2024: $111.6MQ3 2024: $111.4MQ4 2024: $40.1MQ1 2025: $29.1MQ2 2025: $38.6MQ3 2025: $48.0MQ4 2025: $65.4MQ1 2026: $0Q2 2026: $0
Institutions holding RPTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 202546$65.4M
Q3 202545$48.0M
Q2 202550$38.6M
Q1 202550$29.1M
Q4 202454$40.1M
Q3 202456$111.4M
Q2 202461$111.6M
Q1 202471$167.2M
Q4 202369$266.6M
Q3 202376$437.7M
Q2 202378$379.2M
Q1 202377$326.7M
Q4 202282$491.9M
Q3 202271$398.1M
Q2 202271$451.7M
Q1 202262$464.3M
Q4 202167$689.5M
Q3 202166$707.7M
Q2 202161$828.3M
Q1 202165$797.7M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Repare Therapeutics Inc.; share changes are against Q3 2025.

Institutions holding RPTX in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc10,333,600$26.9M0.90%00.0%Unchanged
Blue Owl Capital Holdings LP3,443,659$8.95M2.76%00.0%Unchanged
OrbiMed Advisors LLC3,322,488$8.64M0.18%00.0%Unchanged
Redmile Group, LLC1,586,174$4.12M0.30%00.0%Unchanged
Rangeley Capital, LLC1,287,829$3.35M2.88%+641,953+99.4%Added
Marshall Wace, LLP1,115,744$2.90M0.00%+1,115,744New
Renaissance Technologies LLC981,360$2.55M0.00%+257,200+35.5%Added
Acadian Asset Management LLC618,672$1.61M0.00%+50,371+8.9%Added
Two Sigma Investments, LP333,694$867.6K0.00%+322,727+2,942.7%Added
Jane Street Group, LLC278,304$723.6K0.00%+278,304New
Yakira Capital Management, Inc.266,601$693.2K0.23%+266,601New
Northern Trust Corp260,311$676.8K0.00%−1,890−0.7%Reduced
Citadel Advisors LLC238,912$621.2K0.00%−460,385−65.8%Reduced
BlackRock, Inc.144,219$375.0K0.00%−2,331−1.6%Reduced
Militia Capital Partners, LP119,176$309.9K0.12%00.0%Unchanged
Equitec Proprietary Markets, LLC118,375$307.8K1.48%+118,375New
XTX Topco Ltd116,933$304.0K0.01%+69,386+145.9%Added
Walleye Capital LLC106,683$277.4K0.00%+106,683New
Bank of Montreal104,919$272.8K0.00%00.0%Unchanged
Two Sigma Advisers, LP54,200$140.9K0.00%+26,500+95.7%Added
Point72 Asset Management, L.P.51,252$133.3K0.00%+51,252New
HRT Financial LP42,301$109.0K0.00%+42,301New
Quinn Opportunity Partners LLC40,000$104.0K0.00%00.0%Unchanged
FNY Investment Advisers, LLC35,000$91.0K0.03%+35,000New
NewEdge Wealth, LLC32,959$85.7K0.00%00.0%Unchanged
Virtu Financial LLC15,488$40.0K0.00%+15,488New
Squarepoint Ops LLC14,485$37.7K0.00%−50,758−77.8%Reduced
Occudo Quantitative Strategies LP13,548$35.2K0.00%+13,548New
Covestor Ltd13,627$35.0K0.02%+13,627New
HarbourVest Partners LLC12,276$31.9K0.02%00.0%Unchanged
Engineers Gate Manager LP11,627$30.2K0.00%+124+1.1%Added
Bank of America Corp10,737$27.9K0.00%−2,118−16.5%Reduced
StoneX Group Inc.10,603$27.6K0.00%+10,603New
CIBC World Markets Inc.10,500$27.3K0.00%00.0%Unchanged
Stifel Financial Corp10,000$26.0K0.00%−67,600−87.1%Reduced
Federation des caisses Desjardins du Quebec2,259$5.87K0.00%+2,000+772.2%Added
SBI Securities Co., Ltd.1,252$3.25K0.00%−10−0.8%Reduced
TD Waterhouse Canada Inc.1,250$3.25K0.00%00.0%Unchanged
Barclays PLC530$1.38K0.00%00.0%Unchanged
Curio Wealth, LLC500$1.27K0.00%+500New
Morgan Stanley404$1.05K0.00%−6,334−94.0%Reduced
Royal Bank of Canada200$1.00K0.00%00.0%Unchanged
Jones Financial Companies LLLP100$2600.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC11$290.00%00.0%Unchanged
JPMorgan Chase & Co4$100.00%00.0%Unchanged
BNP Paribas Arbitrage, SA1$30.00%00.0%Unchanged
Versant Venture Management, LLC0$00.00%−2,646,657−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−819,924−100.0%Sold out
Affinity Asset Advisors, LLC0$00.00%−200,000−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−40,000−100.0%Sold out
Ieq Capital, LLC0$00.00%−38,382−100.0%Sold out
Blackstone Group Inc.0$00.00%−25,957−100.0%Sold out
Lantern Wealth Advisors, LLC0$00.00%−20,000−100.0%Sold out
Prudential Financial Inc0$00.00%−14,900−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−13,862−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−12,500−100.0%Sold out
UBS Group AG0$00.00%−3,553−100.0%Sold out
MPM Asset Management LLC––––Not filed